NAYA Biosciences (NASDAQ:NAYA – Get Free Report) is expected to release its earnings data before the market opens on Monday, April 14th. Analysts expect NAYA Biosciences to post earnings of ($0.29) per share and revenue of $1.50 million for the quarter.
NAYA Biosciences Stock Performance
NAYA stock opened at $1.83 on Monday. The business has a 50-day moving average price of $3.86. NAYA Biosciences has a fifty-two week low of $1.72 and a fifty-two week high of $42.00.
Analyst Ratings Changes
Separately, Maxim Group upgraded shares of NAYA Biosciences from a “hold” rating to a “buy” rating and set a $24.00 price target on the stock in a research note on Thursday, January 23rd.
NAYA Biosciences Company Profile
NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.
Featured Articles
- Five stocks we like better than NAYA Biosciences
- 3 Healthcare Dividend Stocks to Buy
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- Business Services Stocks Investing
- Disney 2025 Shareholders: Major Updates for Investors
- How to Buy Cheap Stocks Step by Step
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for NAYA Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NAYA Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
